The global pharmaceutical industry relies heavily on a robust supply chain for active pharmaceutical ingredients (APIs) and their essential intermediates. For those involved in the production of Ibrutinib, a vital oncology drug, securing a consistent supply of 5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile (CAS: 330792-70-6) is a critical step. This article explores the landscape of suppliers for this specific intermediate, offering insights for buyers seeking reliable sources worldwide.

When initiating a search for this compound, common search terms include '5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile for sale' or 'pharmaceutical intermediate wholesale'. Buyers are often looking for manufacturers based in regions known for chemical production expertise, such as China, India, and the United States. These regions host numerous companies that specialize in fine chemicals and pharmaceutical intermediates, capable of meeting stringent quality requirements.

Key criteria for selecting a supplier include the guaranteed purity (typically ≥98.0%), availability of comprehensive documentation (CoA, MSDS), competitive pricing, and responsiveness to inquiries. For instance, a supplier based in China might offer significant price advantages due to manufacturing scale and cost efficiencies, while still adhering to international quality standards. Companies like those based in Jinan or Shanghai are frequently cited for their expertise in producing complex organic intermediates.

Beyond just the product itself, buyers often assess the supplier's overall service. This can include the ability to provide custom packaging, ensure timely delivery through reliable logistics partners, and offer technical support. The 'Request for Quotation' (RFQ) process is a standard method for engaging potential suppliers, allowing buyers to compare offers based on price, lead time, and product specifications. Ultimately, establishing a relationship with a trusted manufacturer or supplier for 5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile is essential for the efficient and reliable production of Ibrutinib.